Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial
Titel:
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial
Auteur:
Ambrose, Emmanuela E Latham, Teresa S Songoro, Primrose Charles, Mwesige Lane, Adam C Stuber, Susan E Makubi, Abel N Ware, Russell E Smart, Luke R